 | Up a level |
Number of items: 1.
Ettrich, T., Perkofer, L., Berger, A. W., Guethle, M., Behl, S., Zipprich, A., Woerns, M. A., Waldschmidt, D. T., Belle, S., Michl, P., Seufferlein, T. and Dollinger, M. M. (2015). Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trial. Eur. J. Cancer, 51. S. S457 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852